Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Tax Provisions: 2013-2023

Historic Tax Provisions for ImmunityBio (IBRX) over the last 11 years, with Dec 2023 value amounting to -$40,000.

  • ImmunityBio's Tax Provisions was N/A to -$35,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9,000, marking a year-over-year change of. This contributed to the annual value of -$40,000 for FY2023, which is 217.65% down from last year.
  • Latest data reveals that ImmunityBio reported Tax Provisions of -$40,000 as of FY2023, which was down 217.65% from $34,000 recorded in FY2022.
  • Over the past 5 years, ImmunityBio's Tax Provisions peaked at $34,000 during FY2022, and registered a low of -$1.8 million during FY2020.
  • In the last 3 years, ImmunityBio's Tax Provisions had a median value of $9,000 in 2021 and averaged $1,000.
  • In the last 5 years, ImmunityBio's Tax Provisions tumbled by 1,658.10% in 2020 and then soared by 277.78% in 2022.
  • ImmunityBio's Tax Provisions (Yearly) stood at -$105,000 in 2019, then tumbled by 1,658.10% to -$1.8 million in 2020, then spiked by 100.49% to $9,000 in 2021, then spiked by 277.78% to $34,000 in 2022, then plummeted by 217.65% to -$40,000 in 2023.